Hib vaccine (Sanofi Pasteur/BioPort)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHib vaccine (Sanofi Pasteur/BioPort)
Drug Alias NameHin 47Haemophilus influenzae vaccine - sanofi pasteur/BioPortOtitis media vaccine - sanofi pasteur/BioPort
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis Media
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biodefense Operations Lansing Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent Biodefense Operations Lansing LlcSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsOtitis Media

Other Information

ATC CodeN/A
Related LinksN/A